Zacks: Brokerages Anticipate Medley Capital Corp (MCC) Will Post Quarterly Sales of $20.60 Million

Equities analysts expect Medley Capital Corp (NYSE:MCC) to post sales of $20.60 million for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for Medley Capital’s earnings, with estimates ranging from $19.01 million to $21.67 million. Medley Capital reported sales of $24.36 million in the same quarter last year, which would suggest a negative year over year growth rate of 15.4%. The company is scheduled to report its next earnings report on Tuesday, May 8th.

According to Zacks, analysts expect that Medley Capital will report full year sales of $20.60 million for the current year, with estimates ranging from $76.00 million to $86.06 million. For the next year, analysts expect that the business will post sales of $87.51 million per share, with estimates ranging from $86.00 million to $88.85 million. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side analysts that that provide coverage for Medley Capital.

Medley Capital (NYSE:MCC) last posted its earnings results on Tuesday, February 6th. The investment management company reported $0.13 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.16 by ($0.03). Medley Capital had a negative net margin of 58.73% and a positive return on equity of 7.23%. The company had revenue of $20.63 million during the quarter, compared to the consensus estimate of $22.19 million. During the same quarter in the prior year, the business earned $0.19 EPS. The firm’s revenue for the quarter was down 20.8% compared to the same quarter last year.

A number of research analysts have recently weighed in on MCC shares. ValuEngine upgraded Medley Capital from a “hold” rating to a “buy” rating in a report on Friday, December 1st. National Securities restated a “neutral” rating and issued a $6.00 target price on shares of Medley Capital in a report on Thursday, December 7th. Keefe, Bruyette & Woods set a $6.00 target price on Medley Capital and gave the company a “hold” rating in a report on Friday, December 8th. Zacks Investment Research lowered Medley Capital from a “hold” rating to a “sell” rating in a report on Wednesday, December 13th. Finally, Barclays decreased their price target on Medley Capital from $7.00 to $5.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 7th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $5.63.

Several institutional investors and hedge funds have recently modified their holdings of the stock. American Financial Group Inc. increased its position in shares of Medley Capital by 3.4% during the fourth quarter. American Financial Group Inc. now owns 2,274,013 shares of the investment management company’s stock valued at $11,870,000 after acquiring an additional 74,155 shares during the last quarter. Roumell Asset Management LLC increased its position in Medley Capital by 125.9% in the fourth quarter. Roumell Asset Management LLC now owns 984,550 shares of the investment management company’s stock worth $5,139,000 after buying an additional 548,680 shares during the last quarter. Sumitomo Mitsui Asset Management Company LTD increased its position in Medley Capital by 9.7% in the third quarter. Sumitomo Mitsui Asset Management Company LTD now owns 574,068 shares of the investment management company’s stock worth $3,427,000 after buying an additional 50,761 shares during the last quarter. Ladenburg Thalmann Financial Services Inc. increased its position in Medley Capital by 45.2% in the fourth quarter. Ladenburg Thalmann Financial Services Inc. now owns 489,335 shares of the investment management company’s stock worth $2,555,000 after buying an additional 152,253 shares during the last quarter. Finally, Rational Advisors LLC purchased a new stake in Medley Capital in the fourth quarter worth $2,442,000. 28.51% of the stock is owned by institutional investors.

Medley Capital (NYSE:MCC) opened at $4.34 on Thursday. Medley Capital has a fifty-two week low of $4.15 and a fifty-two week high of $7.98. The company has a quick ratio of 5.02, a current ratio of 5.02 and a debt-to-equity ratio of 1.11. The firm has a market capitalization of $236.42, a P/E ratio of -4.43, a PEG ratio of 1.56 and a beta of 1.15.

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 23rd. Investors of record on Wednesday, February 21st will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 14.75%. The ex-dividend date of this dividend is Tuesday, February 20th. Medley Capital’s payout ratio is -65.31%.

TRADEMARK VIOLATION NOTICE: This piece was posted by American Banking News and is owned by of American Banking News. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of international trademark and copyright law. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2018/02/15/zacks-brokerages-anticipate-medley-capital-corp-mcc-will-post-quarterly-sales-of-20-60-million.html.

About Medley Capital

Medley Capital Corporation is a non-diversified closed-end management investment company. The Company’s investment objective is to generate current income and capital appreciation by lending directly to privately-held middle market companies, primarily through directly originated transactions to help these companies expand their business, refinance and make acquisitions.

Get a free copy of the Zacks research report on Medley Capital (MCC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Medley Capital (NYSE:MCC)

Receive News & Ratings for Medley Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medley Capital and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply